Andy Plump (Jeff Rumans for Endpoints News @ JPM19)
MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner
As far as biological branding goes, it’s hard to beat natural killer cells.
These immune responders earned their moniker in the ’70s for their apparent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
